One of the persistent frustrations with GLP-1 weight loss drugs is the commitment they require. Weekly injections, strict maintenance dosing,...
Lilly
Eli Lilly (LLY) has spent 2026 defending its lead in the weight-loss drug market, mostly with injections. That approach is...
Eli Lilly (LLY) posted a second-quarter result strong enough to shift the debate around its stock.For months, the debate centered...
Eli Lilly (LLY) stock has turned into one of the best comeback trades of 2026.Shares closed at $1,196.03 on July...
Check out what's clicking on FoxBusiness.com. Novo Nordisk sued Eli Lilly on Tuesday, accusing its rival of misleading consumers by...
Eli Lilly (LLY) has seen a lot of bullish calls from Wall Street in July. Guggenheim, Truist, Bank of America, Bernstein,...
Eli Lilly (LLY) climbed to new record highs in the final week of June, driven by strong sales of its...
On Thursday morning in New York City, Dr. Shiv Rao stood before a room of health system executives and made...
Eli Lilly (LLY) just did something worth paying attention to. With CVS Caremark announcing coverage of both Zepbound and newly...
Picture a drug so popular that, even in markets where a cheaper generic competitor had just launched, it still grew...
There's a reason the world's most patient investors love dividend stocks.Market movements heavily influence a stock's capital-gains potential in a...
Eli Lilly (LLY) stock initially sold off on Monday morning, May 4, after the FDA disclosed a liver failure report...